Abstract

The signaling lymphocyte activation molecule (SLAM) family plays important roles in adaptive immune responses. Herein, we evaluated whether the SLAM family member 2B4 (CD244) plays a role in immune cell development, homeostasis and antibody responses. We found that the splenic cellularity in Cd244 -/- mice was significantly reduced due to a reduction in both CD4 T cells and follicular (Fo) B cells; whereas, the number of peritoneal cavity B cells was increased. These findings led us to examine whether 2B4 modulates B cell immune responses. When we examined T-dependent B cell responses, while there was no difference in the kinetics or magnitude of the antigen-specific IgM and IgG1 antibody response there was a reduction in bone marrow (BM) memory, but not plasma cells in Cd244 -/- mice. When we evaluated T-independent immune responses, we found that antigen-specific IgM and IgG3 were elevated in the serum following immunization. These data indicate that 2B4 dampens T-independent B cell responses due to a reduction in peritoneal cavity B cells, but has minimal impact on T-dependent B cell responses.

Highlights

  • 2B4 is a member of the signaling lymphocyte activation molecule (SLAM)-related receptor family and is known as SLAMF4 and CD244 [1]

  • We found that peritoneal cavity B cells were increased in Cd244-/- mice due to a significant increase in B1b and B2, but not B1a cells

  • We found that Cd244-/- mice had a significant reduction in splenic cellularity (Fig 1A)

Read more

Summary

Introduction

2B4 is a member of the signaling lymphocyte activation molecule (SLAM)-related receptor family and is known as SLAMF4 and CD244 [1]. Following immunization with a T-independent antigen, Cd244-/- mice exhibited a significant increase in antigen-specific IgM production on day 14 and isotype-class switched IgG3 on days seven and 14. We repeated the splenic phenotyping and calculated absolute numbers of cells to determine the specific immune cell populations that are reduced in Cd244-/- mice in our colony.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.